Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From AngioDynamics, Inc.
2019 saw fewer revenue-boosting major acquisitions by top-tier medtechs. Companies that reported after the calendar year-end were the first to see the consequences of the pandemic on their annual figures.
“The spin-off will establish two separate companies, a fully integrated, pure play, eye health company built on the iconic Bausch Health brand and a long history of innovation, and an international diversified pharmaceutical company with leading physicians in gastroenterology, dermatology, aesthetics, neurology and an international pharma business,” says CEO Joseph Papa.
The company formerly known as Valeant, put together by a series of mergers, is ready to spin out the legacy Bausch + Lomb eyecare business that it used in its rebranding.
Israeli healthtech fund Accelmed is raising $100m for its fourth fund focused on medical device and digital health companies.
- Radiopharmaceuticals, Contrast Agents
- Consumables, Central Supplies
- Diagnostic Equipment & Supplies
- Monitoring Equipment & Devices
- Radiofrequency Devices
Surgical Equipment & Devices
- Minimally or Less Invasive
Diagnostic Imaging Equipment & Supplies
- Digital Imaging
- Other Names / Subsidiaries
- Eximo Hybrid Medical Technologies
- Eximo Medical Ltd.
- Microsulis Medical Ltd.
- Navilyst Medical
- Vortex Meidcal, Inc.